suberoyl bis-hydroxamic acid has been researched along with Acute Myelogenous Leukemia in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, YH | 1 |
| Yang, CM | 1 |
| Qian, WB | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[Antitumor activity of histone deacetylase inhibitor suberic bishydroxamate on acute myeloid leukemia cell lines].
Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cell Line, Tumor; Histone Deacetylase Inhibitors | 2012 |